Siberian Ginseng for Dogs: EMA-Approved Adaptogen for Stamina

Summary

Siberian Ginseng (known scientifically as Eleuthero or Eleutherococcus senticosus) is one of six Core strict-definition adaptogens within the Brekhman and Dardymov 1969 framework, sitting alongside Ashwagandha, Panax Ginseng, Holy Basil, Rhodiola, and Schisandra. The European Medicines Agency approves Eleutherococcus senticosus root for the symptomatic treatment of asthenia, fatigue, and weakness, providing an authority signal that few canine nutrition ingredients can match. Direct canine evidence comes from a 2012 Slovak Academy of Sciences study in 32 healthy dogs, documenting effects on faecal microbiota composition, immune cellular parameters, and tolerability of Siberian Ginseng extract supplementation at 8 mg/kg body weight per day. The bioactive profile is led by eleutherosides B and E (syringin and syringaresinol diglucoside), caffeoylquinic acids, lignans, polysaccharides, and isofraxidine, with documented activity across stress-axis modulation, immune modulation, physical endurance, cognitive function, antioxidant capacity, and glucose metabolism mechanisms. Siberian Ginseng is included in Bonza Superfoods & Ancient Grains within the PhytoPlus® botanical blend and in Boost Bioactive Bites, with cold extrusion at 70°C preserving the heat-sensitive bioactivity that conventional pet food processing destroys.

Siberian Ginseng has been used in traditional medicine across Eastern Russia, China, Korea, and Japan for over two thousand years, but its modern scientific story begins in 1958 when Soviet pharmacologist Israel Brekhman published the first peer-reviewed article on the plant. Over the following two decades, more than 1,000 studies were conducted on Siberian Ginseng across 70 USSR research institutes, leading to its approval for clinical use as a stamina and recovery aid in 1962 and its industrial-scale production from 1964 onwards.¹,² The plant was central to the original 1969 Brekhman and Dardymov definition of adaptogens that still underpins the field today, and Soviet researchers ranked it among the most pharmacologically active of the classical adaptogens identified.²,³

Despite the consumer-facing name “Siberian Ginseng,” the plant is not a true ginseng. Eleutherococcus senticosus belongs to the Araliaceae family and is only distantly related to Panax ginseng (Asian ginseng). The “Siberian Ginseng” name was coined in the United States in reference to the plant’s Siberian export origin, while the formally accepted scientific common name is Eleuthero.⁴ For a dog owner researching adaptogenic herbs, the practical consequence is that Siberian Ginseng and Eleuthero are the same plant, and the two terms are used interchangeably throughout this article.

For broader context on the strict-definition adaptogen framework that places Siberian Ginseng alongside Ashwagandha, Panax Ginseng, Holy Basil, Rhodiola, and Schisandra as one of six Core adaptogens, see the Adaptogens for Dogs hub. This article covers Siberian Ginseng specifically, explains the canine and translational evidence base, and details how the herb is incorporated into Bonza Superfoods & Ancient Grains and Boost Bioactive Bites.

Key Takeaways

• Siberian Ginseng (Eleuthero) is one of six Core strict-definition adaptogens, with the original 1969 Brekhman and Dardymov definition explicitly built around the plant’s documented capacity to increase non-specific resistance to stress.
• The European Medicines Agency approves Eleutherococcus senticosus root for the symptomatic treatment of asthenia, fatigue, and weakness, providing a regulatory authority signal that very few canine nutrition ingredients can match.
• Direct canine evidence comes from the 2012 Strompfová et al. Slovak Academy of Sciences study in 32 healthy dogs, documenting tolerability and effects on faecal microbiota composition and cellular immunity at 8 mg/kg body weight per day over a 14-day supplementation period within a 49-day trial.
• Eleutherosides B and E are the principal pharmacological markers, with caffeoylquinic acids, lignans, polysaccharides, flavonoids, and isofraxidine completing the bioactive profile.
• Documented benefit areas include HPA-axis stress modulation, physical endurance, cognitive support (particularly relevant in senior contexts), immunomodulation, antioxidant activity, and glucose metabolism mechanism support.
• Siberian Ginseng appears in Bonza Superfoods & Ancient Grains within the 28-ingredient PhytoPlus® blend and in Boost Bioactive Bites, the senior-focused multivitamin formulation.
• The 8 mg/kg body weight per day dose used in the Strompfová canine trial provides the most defensible canine dosing parameter currently available in the published peer-reviewed literature.
• Veterinary input is appropriate for dogs on cardiac medication (particularly digoxin), with diagnosed bleeding or blood pressure conditions, on hormone-sensitive medication, in pregnancy or lactation, or in the two weeks before any planned surgery.

In This Guide

• What Siberian Ginseng Is and Why It Matters for Dogs
• The Bioactive Composition of Siberian Ginseng
• The Documented Benefits of Siberian Ginseng for Dogs
• How Siberian Ginseng Influences the Canine Gut Microbiome and Gut-Organ Axes
• Why Bonza Includes Siberian Ginseng in Superfoods & Ancient Grains and Boost
• Safety, Contraindications, and When to Seek Veterinary Input
• How to Introduce Siberian Ginseng into Your Dog’s Routine
• Dosage Guidance for Siberian Ginseng in Dogs
• Frequently Asked Questions
• Conclusion
• Related Articles
• References
• Editorial Information

What Siberian Ginseng Is and Why It Matters for Dogs

Siberian Ginseng (Eleutherococcus senticosus, also called Eleuthero) is a thorny deciduous shrub belonging to the Araliaceae family, native to the temperate and subtropical forests of Northeast Asia and the Russian Far East. The dried roots and rhizomes are the principal medicinal parts, with the bark and leaves also carrying bioactive compounds at varying concentrations.⁴ The plant has been used in traditional Chinese medicine for over two thousand years under the name “Ciwujia,” in Korean medicine as “Gasiogapi,” and in Japanese medicine as part of the broader Kampo tradition.

Despite its consumer-facing name, Siberian Ginseng is botanically distinct from the true ginsengs (Panax ginseng and Panax quinquefolius). The “ginseng” designation reflects the plant’s similar adaptogenic activity profile rather than any genuine taxonomic relationship.⁴ In the United States, it is technically illegal to label Eleutherococcus senticosus products as “ginseng” alone. The name “Siberian Ginseng” is permitted but “Eleuthero” is the formally accepted common name. For owners researching adaptogenic supplements, this naming distinction matters mainly for understanding ingredient labels: a product labelled “Siberian Ginseng,” “Eleuthero,” or “Eleutherococcus senticosus” is the same plant.

What makes Siberian Ginseng particularly relevant for canine nutrition is the strength and breadth of its evidence base. The plant occupies an unusual position in the adaptogen literature for three reasons:

• It is one of six Core strict-definition adaptogens. Within the Brekhman and Dardymov 1969 framework that established the modern adaptogen category, Siberian Ginseng was specifically named as the lead example of substances meeting the three pharmacological criteria for adaptogen classification: non-toxicity, non-specific resistance to diverse stressors, and normalising bidirectional action.²,³ The plant sits alongside Ashwagandha, Panax Ginseng, Holy Basil, Rhodiola, and Schisandra as the six Core adaptogens with the strongest mechanistic and clinical evidence base.
• It carries European Medicines Agency authorisation. The EMA approves Eleutherococcus senticosus root for the symptomatic treatment of asthenia, fatigue, and weakness, a regulatory authority signal that very few herbal ingredients in any species achieve.⁵ This sets Siberian Ginseng apart from the broader category of adaptogens and from most other ingredients commonly used in canine nutrition.
• It has direct canine peer-reviewed evidence. The 2012 Strompfová et al. study from the Slovak Academy of Sciences supplemented 32 healthy dogs with Siberian Ginseng extract at 8 mg/kg body weight per day, documenting effects on faecal microbiota, immune cellular parameters, and tolerability over a 49-day trial with 14 days of active supplementation.⁶ While limited in scale relative to the Reishi canine RCT, this direct canine study provides the most defensible canine dosing parameter currently available in the published peer-reviewed literature.

The combination of Core adaptogen classification, EMA regulatory authority signal, and direct canine evidence places Siberian Ginseng among the best-characterised adaptogens for inclusion in canine nutrition. For owners researching options for supporting their dog’s stress resilience, stamina, cognitive function, and senior vitality, this evidence base is what justifies serious editorial attention to the plant.

The Bioactive Composition of Siberian Ginseng

Siberian Ginseng’s pharmacological breadth comes from a diverse and well-characterised bioactive profile. Modern phytochemistry has isolated multiple distinct compound classes from Eleutherococcus senticosus, with the eleutherosides serving as the principal pharmacological markers and the caffeoylquinic acids, lignans, polysaccharides, flavonoids, and isofraxidine completing the active matrix.⁵,⁷ Two compounds in particular, eleutheroside B (syringin) and eleutheroside E (syringaresinol diglucoside), are used as standardisation markers for Eleutherococcus products globally, and syringin specifically serves as the discriminating marker that distinguishes E. senticosus from other Araliaceae plant materials.

Eleutherosides B and E

The eleutherosides are a group of liposoluble phenylpropanoid and lignan glycosides found primarily in the roots and stem bark of Eleutherococcus senticosus. Eleutheroside B (syringin) is a phenylpropanoid glucoside with documented anti-fatigue, anti-oxidation, and neuroprotective activity.⁵ Eleutheroside E (syringaresinol diglucoside) is a lignan glycoside with documented anti-inflammatory, immunomodulatory, and glucose metabolism activities.⁵,⁸ Together, these two compounds account for the majority of pharmacological characterisation work conducted on the plant.

The mechanism of action of the eleutherosides operates across multiple pathways. They modulate inflammatory signalling through inhibition of NF-κB and MAPK pathway activation, contribute to immune cell signalling through pattern recognition receptor engagement, and influence neurotrophic factor expression including brain-derived neurotrophic factor (BDNF) in hippocampal tissue.⁵ The breadth of mechanism profile is what underpins the plant’s classification as an adaptogen rather than as a single-target intervention.

Caffeoylquinic Acids and Other Phenolics

Caffeoylquinic acids are a major polyphenolic component of Eleutherococcus senticosus root, contributing significantly to the plant’s antioxidant capacity and anti-inflammatory activity.⁵,⁹ Recent phytochemical analysis of the polar and non-polar fractions of E. senticosus root extract identified the ethyl acetate fraction (rich in phenolic acids) as showing the strongest antioxidant activity, with implications that polyphenolic compounds may play a role in adaptogenic action that has been historically attributed primarily to the eleutherosides.⁹

Polysaccharides

Polysaccharides are the principal water-soluble bioactive compounds in Siberian Ginseng and are particularly relevant to immunomodulatory activity. The polysaccharide fraction has been documented to engage Toll-like receptor 4 and Toll-like receptor 2 pathways, triggering immune cell activation including macrophage and natural killer cell stimulation.⁵ For canine nutrition delivered through food rather than encapsulated extract, the polysaccharide content is particularly relevant because it represents the water-soluble fraction most likely to remain bioactive across food-matrix delivery contexts.

Lignans, Saponins, Flavonoids, and Isofraxidine

Beyond the eleutherosides, caffeoylquinic acids, and polysaccharides, Siberian Ginseng contains additional bioactive compounds that contribute to its pharmacological breadth. Lignans (including syringaresinol and sesamin) contribute to anti-inflammatory and antioxidant activity. Saponins provide membrane-active properties relevant to immune cell signalling. Flavonoids add to the antioxidant capacity. Isofraxidine is a coumarin compound with documented anti-inflammatory activity that contributes to the plant’s neuroprotective profile.⁵ The result is a multi-mechanism profile that does not depend on any single bioactive compound, which is one reason Siberian Ginseng extracts deliver consistent effects across heterogeneous individuals despite natural variation in any single compound’s concentration.

The Documented Benefits of Siberian Ginseng for Dogs

The documented benefits of Siberian Ginseng for dogs cover six principal areas: HPA-axis stress modulation (the foundational adaptogenic activity), physical endurance and stamina, cognitive support (particularly relevant in senior contexts), immunomodulation, antioxidant activity, and glucose metabolism mechanism support. Each is covered below proportionate to the strength of the available evidence, with explicit transparency about which findings come from direct canine work, which come from translational human research, and which come from preclinical mechanism studies.

HPA-Axis Stress Modulation: The Foundational Adaptogenic Activity

Siberian Ginseng’s foundational benefit is its bidirectional modulation of the hypothalamic-pituitary-adrenal axis, the neuroendocrine system that governs the body’s response to stressors of all kinds. As one of six Core strict-definition adaptogens within the Brekhman and Dardymov 1969 framework, Siberian Ginseng was specifically named in the original definition as exemplifying the three pharmacological criteria for adaptogenic action: non-toxicity at therapeutic dose, non-specific resistance to diverse stressors (physical, chemical, biological, and psychological), and normalising bidirectional effect regardless of the direction of pre-existing imbalance.²,³ This is the editorial definition that anchors Siberian Ginseng’s place in the adaptogen literature.

The mechanism of HPA-axis modulation operates through stress-protective effects on neuroendocrine signalling, with documented influences on cortisol metabolism pathways, neurotrophic factor expression, and stress-responsive gene transcription.²,⁵ The adaptogenic mechanism is shared with the other five Core adaptogens (Ashwagandha, Panax Ginseng, Holy Basil, Rhodiola, Schisandra), with Siberian Ginseng’s specific contribution being its particularly strong evidence base for fatigue and asthenia outcomes and its EMA-approved indication for these symptoms.⁵

Physical Endurance and Stamina

Siberian Ginseng’s effects on physical endurance and stamina represent one of the most extensively researched areas of the plant’s pharmacology, drawing on both Soviet-era research compiled in the 2021 Gerontakos et al. review (covering 46 USSR studies between 1962 and 1986 documenting consistent stamina effects across healthy volunteers under varied conditions) and contemporary peer-reviewed clinical trials.² A 2010 randomised controlled trial documented that 8 weeks of supplementation at 800 mg per day produced VO2 peak improvement of 12 percent and endurance time improvement of 23 percent in recreationally trained males, with statistical significance for both endpoints.¹⁰

The evidence base for endurance and stamina is not uniformly positive. A 2005 critical review by Goulet and Dionne identified methodological limitations in earlier studies that the authors argued threatened the internal validity of stamina-related conclusions, and subsequent trials have produced mixed results.¹¹ The honest editorial conclusion is that Siberian Ginseng has documented activity in physical endurance contexts, with the strongest signal coming from longer-duration supplementation protocols. For dogs, this translates to a reasonable expectation of stamina-supporting effects from sustained daily supplementation, particularly in older dogs experiencing age-related decline in physical vitality.

Eleuthero supports stamina and recovery, rounding out the adaptogen quartet. It features in Bonza’s plant-based dog food.

Cognitive Support and Senior Vitality

Siberian Ginseng’s cognitive support evidence is particularly relevant to the senior dog use case. The 2004 Cicero et al. randomised clinical trial supplemented 20 elderly volunteers (aged 65 and over) with hypertension and heart disease with Siberian Ginseng for 8 weeks, documenting significantly improved scores on social functioning, mental health, and the mental component summary scales compared with placebo, with no adverse events observed.¹² This study is particularly important because the population (elderly subjects with concurrent cardiovascular conditions) is the closest human translational analogue to senior dogs experiencing age-related decline.

The mechanism of cognitive support is mediated by the eleutherosides and lignans engaging brain-derived neurotrophic factor (BDNF) expression in hippocampal tissue, with documented effects on neurogenesis, synaptic plasticity, and memory function in animal models.⁵ A 2020 placebo-controlled randomised trial in healthy adults documented that combined Eleutherococcus and Drynaria fortunei extract supplementation produced significant cognitive enhancement on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) test, with intergroup improvement in figure recall reaching statistical significance.¹³

For dogs, the cognitive evidence supports Siberian Ginseng as a contributor to age-related cognitive support strategies, sitting alongside Panax Ginseng (which has the strongest direct geriatric canine cognitive evidence in the adaptogen category) within the broader gut-brain axis approach to canine cognitive ageing.

Immunomodulation

Siberian Ginseng’s immunomodulatory activity is well-characterised across human clinical, mechanistic, and translational research. The classic 1987 Bohn et al. flow cytometry study supplemented 36 healthy volunteers with Siberian Ginseng extract for 4 weeks, documenting drastic increases in the absolute number of immunocompetent cells with particularly pronounced effects on T helper lymphocytes and additional effects on cytotoxic T cells and natural killer cells.¹⁴ Subsequent mechanistic work has characterised the activity through pattern recognition receptor engagement, including Toll-like receptor 2 and Toll-like receptor 4 pathways on macrophages and dendritic cells.⁵

The 2005 Narimanian et al. randomised trial of the KanJang fixed combination (Adhatoda vasica, Echinacea purpurea, Eleutherococcus senticosus) documented significantly greater improvement in upper respiratory tract infection symptoms compared with standard treatment, providing clinical-context support for the immunomodulatory mechanism.¹⁵ The direct canine evidence from the Strompfová 2012 study documented effects on cellular immunity parameters in healthy dogs, with the supplementation tolerated without adverse effects.⁶

Antioxidant Activity

Siberian Ginseng has documented antioxidant activity mediated by its phenolic content (particularly the caffeoylquinic acids), the eleutherosides, and the polyphenolic ethyl acetate fraction of the root.⁵,⁹ The activity is documented across DPPH, ABTS, FRAP, CUPRAC, and superoxide anion scavenging assays, with the ethyl acetate fraction showing IC50 values of 82.73 µg/mL (DPPH) and 9.92 µg/mL (ABTS).⁹ For dogs, the antioxidant activity is relevant in the broader context of oxidative-stress-driven age-related health decline and the inflammaging processes that connect chronic low-grade inflammation to age-related disease.

Glucose Metabolism Mechanism Support

Siberian Ginseng has documented effects on glucose metabolism mechanisms, characterised in detail through the 2013 Ahn et al. study of eleutheroside E in type 2 diabetic db/db mice. The study documented that eleutheroside E increased insulin-provoked glucose uptake in C2C12 myotubes, attenuated TNF-α-induced suppression of glucose uptake in 3T3-L1 adipocytes, decreased blood glucose and serum insulin levels in the diabetic mouse model, and protected pancreatic alpha and beta cells from diabetic damage.⁸ The mechanism operates through insulin signalling pathway modulation and improvements in hepatic glucose metabolism (upregulating glycolysis and downregulating gluconeogenesis).

This evidence is mechanistic preclinical work rather than direct canine clinical evidence. For dogs, the implication is that the glucose-metabolism mechanism is biologically plausible and well-characterised at compound level, but no direct canine RCT evidence exists for diabetes-related outcomes in dogs. The article therefore positions Siberian Ginseng as a potential contributor to general glucose-metabolism support within a broader canine nutrition context, not as a treatment for diagnosed diabetic conditions in dogs. Dogs with diagnosed diabetes mellitus should always be managed under direct veterinary supervision.

How Siberian Ginseng Influences the Canine Gut Microbiome and Gut-Organ Axes

Siberian Ginseng’s effects on the canine gut microbiome and the broader gut-organ axes are central to understanding why an adaptogenic herb delivers systemic benefits across stress, immune, cognitive, and metabolic outcomes. The 2012 Strompfová canine study is particularly important here because it specifically measured faecal microbiota composition alongside immune and biochemical parameters, providing direct canine evidence for gut-anchored systemic activity rather than requiring extrapolation from translational research.⁶

Gut Microbiome Modulation (Direct Canine Evidence)

The Strompfová 2012 canine trial documented that Siberian Ginseng supplementation at 8 mg/kg body weight per day produced shifts in faecal microbiota composition in healthy dogs, with both Siberian Ginseng alone and the combination of Siberian Ginseng plus Lactobacillus fermentum probiotic showing distinct effects compared with control across the 49-day trial.⁶ The polysaccharide fraction of Siberian Ginseng is the most likely mechanistic driver, with documented prebiotic-like activity promoting beneficial bacterial populations and supporting short-chain fatty acid production in translational models.⁵ For owners interested in Bonza’s gut-first nutritional philosophy, the existence of direct canine gut-microbiome evidence for Siberian Ginseng makes the inclusion architecturally meaningful rather than speculative.

Gut-Immune Axis

The gut-immune axis is the primary route through which Siberian Ginseng exerts its systemic immune-modulating effects. Approximately 70 percent of canine immune tissue resides in the gut as gut-associated lymphoid tissue (GALT), and Siberian Ginseng’s polysaccharides and eleutherosides engage this tissue through pattern recognition receptors including Toll-like receptors 2 and 4 expressed on intestinal dendritic cells and macrophages.⁵ The Strompfová canine trial documented effects on cellular immunity parameters concurrent with the gut-microbiome shifts, providing canine-specific support for the gut-mediated immune signalling mechanism.⁶

For deeper coverage of the underlying canine gut-immune axis biology, see The Gut-Immune Axis in Dogs.

Gut-Brain Axis

Siberian Ginseng’s gut-brain axis activity is mediated by the eleutherosides and lignans engaging BDNF expression in hippocampal tissue while concurrently modulating gut microbiota composition that influences central nervous system signalling through microbiota-derived metabolites.⁵ The cognitive enhancement evidence (Cicero 2004 in elderly subjects, the 2020 combined extract trial) supports the clinical relevance of this axis activity, while the Strompfová 2012 canine trial provides the gut-microbiome anchor for the canine context.⁶,¹²,¹³

For the canine gut-brain axis context, see The Gut-Brain Axis in Dogs.

Gut-Longevity Axis

The gut-longevity axis provides a frame for understanding Siberian Ginseng’s relevance across the dog’s lifespan, particularly in the senior years where chronic low-grade inflammation, immune system decline, and HPA-axis dysregulation converge on healthspan outcomes. Siberian Ginseng’s combination of antioxidant activity, anti-inflammatory mechanism, gut-microbiota modulation, and adaptogenic HPA-axis normalising activity collectively addresses several biological mechanisms of canine ageing.² The Cicero 2004 elderly RCT showing improved quality-of-life outcomes in subjects with cardiovascular comorbidities provides the strongest translational support for senior-specific benefit.¹²

For the canine gut-longevity axis context, see The Gut-Longevity Axis in Dogs.

Why Bonza Includes Siberian Ginseng in Superfoods & Ancient Grains and Boost

Bonza includes Siberian Ginseng in two products: the Superfoods & Ancient Grains complete, plant-based food (within the 28-ingredient PhytoPlus® botanical and bioactive blend) and Boost Bioactive Bites (the daily multivitamin formulated for senior vitality). The dual-product placement reflects Siberian Ginseng’s role as both a foundational adaptogenic ingredient (delivered through food) and a senior-specific vitality ingredient (delivered through targeted supplementation). PhytoPlus® includes four adaptogens (Ashwagandha, Panax Ginseng, Eleuthero, Reishi) alongside Turmeric with Black Pepper, DHA Gold™ algae-sourced omega-3, prebiotic substrates, polyphenol botanicals, and a comprehensive matrix of bioactive ingredients.

Siberian Ginseng’s specific contribution within Bonza’s formulation architecture rests on four defensible points:

• Direct canine RCT evidence at a dose-aligned inclusion level. The 2012 Strompfová canine trial documented tolerability and effects on faecal microbiota and cellular immunity at 8 mg/kg body weight per day, providing the most defensible canine dosing parameter currently published.⁶ The Bonza inclusion of Siberian Ginseng in both Superfoods & Ancient Grains and Boost is calibrated to deliver meaningful daily exposure within the broader formulation matrix.
• Cold-extrusion processing preserves bioactivity. Conventional pet food extrusion typically operates at 110-130°C, temperatures that degrade heat-sensitive eleutherosides and polysaccharides. Bonza Superfoods & Ancient Grains uses cold-extrusion processing at 70°C, which preserves the bioactive integrity of Siberian Ginseng’s principal compound classes and the broader PhytoPlus® botanical layer. This is a meaningful manufacturing distinction that affects the actual bioavailability of the ingredient list, not just its nominal inclusion.
• Dual-product architecture supports both daily foundational exposure and senior-specific targeted use. Inclusion in Superfoods & Ancient Grains delivers Siberian Ginseng as part of the daily food matrix for all life stages, while inclusion in Boost (the senior-vitality multivitamin) provides targeted additional support for older dogs or owners who specifically want to optimise for cognitive and stamina outcomes documented in the Cicero 2004 elderly RCT and the broader senior-relevant evidence base.¹² The two products work together as a layered approach for owners with senior dogs or with active dogs whose stamina and resilience benefit from additional adaptogenic support.
• Strict-definition Core adaptogen status alongside three other Bonza adaptogens. Within the four-adaptogen architecture of PhytoPlus®, Siberian Ginseng brings its specific profile of EMA-approved fatigue and asthenia indication, documented stamina and endurance support, and senior-cognitive translational evidence. The combination with Ashwagandha (cortisol reduction evidence), Panax Ginseng (cognitive and senior vitality evidence), and Reishi (immune modulation evidence) covers the breadth of HPA-axis activity, immune resilience, cognitive support, and stress-system normalising action through complementary mechanism profiles that produce more consistent results across heterogeneous individual dogs than any single adaptogen on its own.

Shop Bonza Superfoods & Ancient Grains | Shop Boost Bioactive Bites.

Safety, Contraindications, and When to Seek Veterinary Input

Siberian Ginseng has a generally favourable safety profile in dogs at appropriate doses, with the 2012 Strompfová canine trial documenting tolerability at 8 mg/kg body weight per day with no adverse effects on overall health, gut microbiota, or biochemical parameters over a 49-day trial period.⁶ The 2025 Patyra et al. comprehensive review notes that no signs of toxicity have been observed in clinical trials performed with Eleutherococcus senticosus extract in healthy human volunteers, children, or elderly persons across the published clinical literature.⁵ Specific contraindications and cautions exist, however, and veterinary input is appropriate in defined circumstances. The cautions below apply to Siberian Ginseng as an ingredient category rather than to any specific Bonza product, since formulated products deliver Siberian Ginseng within a managed inclusion level alongside a broader nutritional matrix.

Veterinary input is appropriate or essential in the following contexts:

• Cardiac medication, particularly digoxin. Siberian Ginseng has a documented pharmacokinetic interaction with digoxin, with co-administration shown to result in significant increases in serum digoxin levels, likely through altered gastrointestinal absorption or P-glycoprotein inhibition.⁵ Dogs on digoxin or other cardiac medication should not start Siberian Ginseng supplementation without veterinary review.
• Hypertension or hypotension. The cardiovascular effects of Siberian Ginseng are not uniformly characterised across the literature. Dogs with diagnosed blood pressure conditions should be evaluated by a veterinarian before introduction.
• Hormone-sensitive conditions and hormone-affecting medication. Adaptogens by definition influence neuroendocrine signalling. Dogs with diagnosed hormone-sensitive conditions or on hormone-affecting medication should have any Siberian Ginseng supplementation reviewed by their veterinarian.
• Concurrent immunosuppressant medication. Siberian Ginseng’s immune-stimulating activity may partially counteract the action of immunosuppressant drugs. Dogs on these medications, including those used post-transplant or for autoimmune conditions, should have any Siberian Ginseng supplementation reviewed by their veterinarian.
• Pre-surgical contexts. Due to potential effects on stress-response physiology and possible interactions with anaesthetic medications, Siberian Ginseng supplementation should be discontinued at least two weeks before any planned surgery, with the timing confirmed by the supervising veterinary team.
• Pregnancy and lactation. Insufficient canine safety data exists for Siberian Ginseng in pregnancy or lactation. Avoidance is the appropriate default until specific safety evidence becomes available.
• Puppies under 12 months. The 2012 Strompfová canine trial was conducted in adult dogs of varied breeds. No published canine RCT evidence exists for puppies under 12 months. Conservative, veterinary-led decision-making is appropriate in this age group.
• Diagnosed diabetes mellitus. While Siberian Ginseng has documented glucose-metabolism mechanism support, dogs with diagnosed diabetes should always be managed under direct veterinary supervision with any supplementation decisions made by the supervising veterinary team.

The general principle for Siberian Ginseng in canine nutrition, as for the broader adaptogen category, is gradual introduction, daily consistent use, and assessment over weeks rather than days. Adaptogenic effects build progressively through cumulative HPA-axis modulation and microbiome adaptation, not through any single dose.

How to Introduce Siberian Ginseng into Your Dog’s Routine

For dogs already eating Bonza Superfoods & Ancient Grains, Siberian Ginseng is included in the daily food matrix at a managed inclusion level alongside the other three Bonza adaptogens within PhytoPlus®. For owners specifically targeting senior vitality outcomes or wanting additional adaptogenic support layered on top of the food matrix, Bonza Boost provides the targeted multivitamin delivery vehicle with Siberian Ginseng included alongside Ashwagandha and other senior-relevant ingredients.

Dosage Guidance for Siberian Ginseng in Dogs

Dosage guidance for Siberian Ginseng in dogs is more defensibly anchored than for many other adaptogens because of the direct canine RCT evidence at a clearly-specified dose. The 2012 Strompfová canine trial used dry root extract of Eleutherococcus senticosus at 8 mg/kg body weight per day across a 14-day active supplementation period within a 49-day trial, identifying this dose as well-tolerated and producing measurable effects on faecal microbiota composition and cellular immunity parameters.⁶

The practical dosing parameters that emerge from this evidence base are:

• Dry root extract at 8 mg/kg body weight per day is the canine RCT-validated dose for adaptogenic and immunomodulatory support, sustained over 4 to 8 weeks minimum to assess outcome, taken with food.⁶
• Standardised extract products dose depends on eleutheroside B and E concentration. Follow the manufacturer’s veterinary-specific guidance, and where this is not available, default to dose-equivalent amounts based on stated standardisation.
• Food-matrix delivery (Bonza Superfoods & Ancient Grains) daily feeding at the manufacturer’s recommended portion provides Siberian Ginseng alongside the broader PhytoPlus® botanical blend. No additional Siberian Ginseng dosing is required when this food is used.
• Targeted supplementation (Bonza Boost) daily administration at the manufacturer’s recommended portion provides Siberian Ginseng within the senior-vitality multivitamin context, alongside Ashwagandha and other adaptogenic and vitamin support ingredients.

For dogs being introduced to Siberian Ginseng for the first time, beginning at 4 mg/kg body weight per day for the first week and progressing to 8 mg/kg body weight per day from week two onwards is a reasonable protocol that allows tolerance assessment before reaching the evidence-based therapeutic dose. Once at 8 mg/kg, sustained daily dosing for at least 6 to 8 weeks is appropriate before assessing effect.

Frequently Asked Questions

Conclusion

Siberian Ginseng (Eleuthero, scientifically Eleutherococcus senticosus) holds an unusual position in canine nutrition: it is one of six Core strict-definition adaptogens within the Brekhman and Dardymov 1969 framework, it carries European Medicines Agency approval for the symptomatic treatment of asthenia and fatigue, and it has direct peer-reviewed canine evidence from the 2012 Slovak Academy of Sciences study in 32 healthy dogs.²,⁵,⁶ This combination of foundational adaptogen status, regulatory authority signal, and direct canine evidence places Siberian Ginseng among the best-characterised adaptogenic ingredients available for inclusion in dog food and supplements.

The pharmacology that drives Siberian Ginseng’s documented benefits is built around eleutherosides B and E, caffeoylquinic acids, lignans, polysaccharides, flavonoids, and isofraxidine, working through HPA-axis stress modulation, NF-κB and MAPK pathway anti-inflammatory activity, BDNF expression in hippocampal tissue, pattern recognition receptor engagement on immune cells, and gut microbiota modulation through the polysaccharide fraction. The principal route of canine benefit runs through the gut-anchored systemic activity that the 2012 Strompfová trial documented directly, with secondary involvement of the gut-immune, gut-brain, and gut-longevity axes.⁶

Bonza’s inclusion of Siberian Ginseng in both Superfoods & Ancient Grains (within the 28-ingredient PhytoPlus® botanical blend) and Boost Bioactive Bites (the senior-vitality multivitamin) reflects four deliberate architectural choices: alignment with the canine RCT-validated dose, cold-extrusion processing at 70°C to preserve heat-sensitive bioactives, dual-product placement supporting both daily foundational exposure and senior-specific targeted use, and complementary positioning alongside Ashwagandha, Panax Ginseng, and Reishi as the four adaptogens covering the breadth of HPA-axis activity, immune resilience, cognitive support, and stress-system normalising action. One Gut. Whole Dog. is not a slogan in this context. It is the editorial conclusion that the canine Siberian Ginseng literature itself supports through the direct gut-microbiome and immune-cellular evidence the Strompfová trial documented in healthy dogs.

Related Articles

• Adaptogens for Dogs: The Strict-Definition Guide to Adaptogenic Herbs for Stress, Resilience, and Healthy Ageing
• Panax Ginseng for Dogs: A Core Adaptogen for Stress, Cognition, and Senior Vitality
• Reishi Mushroom for Dogs: Benefits, Dosage, and the Canine Evidence
• Adaptogens for Anxiety in Dogs: The Science-Led Guide for Stress, Separation, and Noise Phobia
• The Dog Gut Microbiome: Vital Key to Dog Health
• The Gut-Immune Axis in Dogs
• Bonza Superfoods & Ancient Grains
• Bonza Boost Bioactive Bites

References

1. Brekhman II, Dardymov IV. New substances of plant origin which increase nonspecific resistance. Annu Rev Pharmacol. 1969;9:419-30. doi: 10.1146/annurev.pa.09.040169.002223. PMID: 4892434.
2. Gerontakos S, Taylor A, Avdeeva AY, Shikova VA, Pozharitskaya ON, Casteleijn D, Wardle J, Shikov AN. Findings of Russian literature on the clinical application of Eleutherococcus senticosus (Rupr. & Maxim.): A narrative review. J Ethnopharmacol. 2021;278:114274. doi: 10.1016/j.jep.2021.114274. PMID: 34087398.
3. Panossian AG, Efferth T, Shikov AN, Pozharitskaya ON, Kuchta K, Mukherjee PK, Banerjee S, Heinrich M, Wu W, Guo D, Wagner H. Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress- and aging-related diseases. Med Res Rev. 2021;41(1):630-703. doi: 10.1002/med.21743. PMID: 33103257. PMC: PMC7756641.
4. Davydov M, Krikorian AD. Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. (Araliaceae) as an adaptogen: a closer look. J Ethnopharmacol. 2000;72(3):345-93. doi: 10.1016/S0378-8741(00)00181-1. PMID: 10996277.
5. Patyra A, Kołtun-Jasion M, Kupniewska K, Parzonko A, Kiss AK. Eleutherococcus root: a comprehensive review of its phytochemistry and pharmacological potential in the context of its adaptogenic effect. Front Pharmacol. 2025;16:1683795. doi: 10.3389/fphar.2025.1683795. PMID: 41235111. PMC: PMC12605232.
6. Strompfová V, Plachá I, Čobanová K, Gancarčíková S, Mudroňová D, Lauková A. Experimental addition of Eleutherococcus senticosus and probiotic to the canine diet. Open Life Sci (Cent Eur J Biol). 2012;7(3):436-447. doi: 10.2478/s11535-012-0037-0. [Direct canine study. PMID: not assigned (journal not indexed in PubMed). DOI verified via De Gruyter and Springer Nature.]
7. Kos G, Czarnek K, Sadok I, Krzyszczak-Turczyn A, Kubica P, Fila K, Emre G, Tatarczak-Michalewska M, Latalska M, Blicharska E, Załuski D, Şekeroğlu N, Szopa A. Eleutherococcus senticosus (Acanthopanax senticosus): An Important Adaptogenic Plant. Molecules. 2025;30(12):2512. doi: 10.3390/molecules30122512. PMID: 40572479. PMC: PMC12195798.
8. Ahn J, Um MY, Lee H, Jung CH, Heo SH, Ha TY. Eleutheroside E, An Active Component of Eleutherococcus senticosus, Ameliorates Insulin Resistance in Type 2 Diabetic db/db Mice. Evid Based Complement Alternat Med. 2013;2013:934183. doi: 10.1155/2013/934183. PMID: 23690865. PMC: PMC3638629.
9. Graczyk F, Gębalski J, Makuch-Kocka A, Gawenda-Kempczyńska D, Ptaszyńska AA, Grzyb S, Bogucka-Kocka A, Załuski D. Phenolic Profile, Antioxidant, Anti-Enzymatic and Cytotoxic Activity of the Fruits and Roots of Eleutherococcus senticosus (Rupr. et Maxim.) Maxim. Molecules. 2022;27(17):5579. doi: 10.3390/molecules27175579. PMID: 36080343. PMC: PMC9457789.
10. Kuo J, Chen KW, Cheng IS, Tsai PH, Lu YJ, Lee NY. The effect of eight weeks of supplementation with Eleutherococcus senticosus on endurance capacity and metabolism in human. Chin J Physiol. 2010;53(2):105-11. doi: 10.4077/CJP.2010.AMK018. PMID: 21793317.
11. Goulet ED, Dionne IJ. Assessment of the effects of eleutherococcus senticosus on endurance performance. Int J Sport Nutr Exerc Metab. 2005;15(1):75-83. doi: 10.1123/ijsnem.15.1.75. PMID: 15902991.
12. Cicero AFG, Derosa G, Brillante R, Bernardi R, Nascetti S, Gaddi A. Effects of Siberian ginseng (Eleutherococcus senticosus maxim.) on elderly quality of life: a randomized clinical trial. Arch Gerontol Geriatr Suppl. 2004;(9):69-73. doi: 10.1016/j.archger.2004.04.012. PMID: 15207399.
13. Tohda C, Matsui M, Inada Y, Yang X, Kuboyama T, Kimbara Y, Watari H. Combined Treatment with Two Water Extracts of Eleutherococcus senticosus Leaf and Rhizome of Drynaria fortunei Enhances Cognitive Function: A Placebo-Controlled, Randomized, Double-Blind Study in Healthy Adults. Nutrients. 2020;12(2):303. doi: 10.3390/nu12020303. PMID: 31979283. PMC: PMC7070741.
14. Bohn B, Nebe CT, Birr C. Flow-cytometric studies with eleutherococcus senticosus extract as an immunomodulatory agent. Arzneimittelforschung. 1987;37(10):1193-6. PMID: 2963645.
15. Narimanian M, Badalyan M, Panosyan V, Gabrielyan E, Panossian A, Wikman G, Wagner H. Randomized trial of a fixed combination (KanJang) of herbal extracts containing Adhatoda vasica, Echinacea purpurea and Eleutherococcus senticosus in patients with upper respiratory tract infections. Phytomedicine. 2005;12(8):539-47. doi: 10.1016/j.phymed.2004.10.001. PMID: 16121513.

Editorial Information

Field	Detail
Originally Published	November 2023
Last Updated	May 2026
Update Note	Comprehensive rewrite (May 2026) to apply current strict-definition adaptogen framework, add the 2012 Strompfová canine RCT as the direct canine anchor reference, integrate the EMA-approved adaptogenic indication, expand the gut-organ axis treatment, apply the locked Bonza Ingredient Article Template, and apply verified Vancouver-MD references throughout.
Reviewed by	Glendon Lloyd Dip.Canine.Nutrition Dip.Dog.Nutrigenomics
Next Review	November 2026
Author	Glendon Lloyd Dip.Canine.Nutrition Dip.Dog.Nutrigenomics
Disclaimer	This article is for informational purposes only and does not constitute veterinary advice. Always consult a qualified veterinarian before making changes to your dog’s diet or supplement regimen.